RADDEL, an inter-sectorial European network formed by 11 partners from 7 different countries, has been awarded by the European Commission with a Marie Curie Initial Training Network (ITN) grant under the EU´s FP7 PEOPLE program. The network is formed by leading experts from Universities, Research Centers and Industry willing to share their complementary expertise, infrastructure and facilities for the training of the next generation of top-quality researchers through the development of new science. The project started in February 2012 and will run for 4 years.

The project focuses on the design, synthesis, characterization, pharmacological studies and dosimetry calculations of nanocapsules that contain in their interior radioactive materials for biomedical applications in the areas of cancer diagnosis and therapy. After sealing the chosen radionuclides, the external walls of the nanocapsules will be decorated with biomolecules to render them biocompatible and for targeting purposes. A well structured training program will be also provided with a balanced combination of local and network-wide training through secondments, joint network meetings, workshops, schools, industrial training and the final network conference.

While the training program has been designed to provide the fellows with the necessary expertise to improve their research skills and enhance their career prospects, the scientific program aims to develop novel nanomaterials for biomedical applications. The network expects to go beyond the state-of-the-art, trying to find innovative products and solutions in the field of cancer diagnosis and therapy.

 RADDEL Consortium March2014